Martinez-Picado, J., Zurakowski, R., Buzón, M. J., & Stevenson, M. (2018).
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
Retrovirology, 15(1), 15. https://doi.org/10.1186/s12977-018-0398-1
Pérez-Molina, J. A., Martínez, E., Blasco, A. J., Arribas, J. R., Domingo, P., Iribarren, J. A., … Gatell, J. M. (2018).
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.
Enfermedades Infecciosas y Microbiologia Clinica. https://doi.org/10.1016/j.eimc.2018.04.010
Negredo, E., & Clotet, B. (2018).
Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1.
Expert Opinion on Pharmacotherapy, 19(8), 929–934. https://doi.org/10.1080/14656566.2018.1472766
Sotzny, F., Blanco, J., Capelli, E., Castro-Marrero, J., Steiner, S., Murovska, M., … European Network on ME/CFS (EUROMENE). (2018).
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease.
Autoimmunity Reviews, 17(6), 601–609. https://doi.org/10.1016/j.autrev.2018.01.009
Kobayashi-Ishihara, M., Terahara, K., Martinez, J. P., Yamagishi, M., Iwabuchi, R., Brander, C., … Tsunetsugu-Yokota, Y. (2018).
HIV LTR-Driven Antisense RNA by Itself Has Regulatory Function and May Curtail Virus Reactivation From Latency.
Frontiers in Microbiology, 9, 1066. https://doi.org/10.3389/fmicb.2018.01066
Inzaule, S. C., Hamers, R. L., Noguera-Julian, M., Casadellà, M., Parera, M., Rinke de Wit, T. F., & Paredes, R. (2018).
Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
Journal of Antimicrobial Chemotherapy, 73(5), 1167–1172. https://doi.org/10.1093/jac/dky005
Rupérez, M., Noguera-Julian, M., González, R., Maculuve, S., Bellido, R., Vala, A., … Menéndez, C. (2018).
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
PLOS ONE, 13(5), e0196451. https://doi.org/10.1371/journal.pone.0196451
Negredo, E., Domingo, P., Gutiérrez, F., Galindo, M. J., Knobel, H., Lozano, F., … Estrada, V. (2018).
Executive summary of the consensus document on osteoporosis in HIV-infected individuals.
Enfermedades Infecciosas y Microbiología Clínica, 36(5), 312–314. https://doi.org/10.1016/j.eimc.2017.03.010
Coll, J., Videla, S., Leon, A., Ornelas, A., García, F., Fernández, E., … González, V. (2018).
Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with men.
Clinical Microbiology and Infection, 24(5), 540–545. https://doi.org/10.1016/j.cmi.2017.08.012
Santos, J., Cozzi-Lepri, A., Phillips, A., De Wit, S., Pedersen, C., Reiss, P., … Lundgren, J. (2018).
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.
HIV Medicine, 19(5), 324–338. https://doi.org/10.1111/hiv.12581
Rodríguez-Gallego, E., Gómez, J., Pacheco, Y. M., Peraire, J., Viladés, C., Beltrán-Debón, R., … Vidal, F. (2018).
A baseline metabolomic signature is associated with immunological CD4 + T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.
AIDS, 32(5), 565–573. https://doi.org/10.1097/QAD.0000000000001730
Pastor, L., Urrea, V., Carrillo, J., Parker, E., Fuente-Soro, L., Jairoce, C., … Blanco, J. (2018).
Dynamics of CD4 and CD8 T-cell subsets and inflammatory biomarkers during early and chronic HIV infection in Mozambican adults.
Frontiers in Immunology, 8(JAN). https://doi.org/10.3389/fimmu.2017.01925
López, J. J., Pérez-Àlvarez, N., Rodríguez, R. V., Jou, A., Carbonell, P., Jiménez, J. A., … Tural, C. (2018).
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice.
Journal of Ultrasound in Medicine, 37(1), 113–121. https://doi.org/10.1002/jum.14312
Carrillo, J., Negredo, E., Puig, J., Molinos-Albert, L. M., Rodríguez De La Concepción, M. L., Curriu, M., … Blanco, J. (2018).
Memory B cell dysregulation in HIV-1-infected individuals.
AIDS, 32(2), 149–160. https://doi.org/10.1097/QAD.0000000000001686
Llibre, J. M., de Lazzari, E., Molina, J.-M., Gallien, S., Gonzalez-García, J., Imaz, A., … Gatell, J. M. (2018).
Cost–effectiveness of initial antiretroviral treatment administered as single vs. multiple tablet regimens with the same or different components | Coste-efectividad del tratamiento inicial antirretroviral de comprimido único vs. tratamiento con regímenes
Enfermedades Infecciosas y Microbiologia Clinica, 36(1), 16–20. https://doi.org/10.1016/j.eimc.2016.07.006
Moltó, J., Curran, A., Miranda, C., Challenger, E., Santos, J. R., Ribera, E., … Clotet, B. (2018).
Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patients.
Journal of Antimicrobial Chemotherapy, 73(3), 732–737. https://doi.org/10.1093/jac/dkx459
Adland, E., Hill, M., Lavandier, N., Csala, A., Edwards, A., Chen, F., … Goulder, P. (2018).
Differential immunodominance hierarchy of CD8+T-cell responses in HLA-B*27:05- and -B*27:02-mediated control of HIV-1 infection.
Journal of Virology, 92(4). https://doi.org/10.1128/JVI.01685-17
Abdel-Mohsen, M., Kuri-Cervantes, L., Grau-Exposito, J., Spivak, A. M., Nell, R. A., Tomescu, C., … Montaner, L. J. (2018).
CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.
Science Translational Medicine, 10(437). https://doi.org/10.1126/scitranslmed.aar6759
Casado, C., Marrero-Hernández, S., Márquez-Arce, D., Pernas, M., Marfil, S., Borràs-Grañana, F., … Lopez-Galíndez, C. (2018).
Viral characteristics associated with the clinical nonprogressor phenotype are inherited by viruses from a cluster of HIV-1 elite controllers.
MBio, 9(2). https://doi.org/10.1128/mBio.02338-17
Olvera, A., Martinez, J. P., Casadellà, M., Llano, A., Rosás, M., Mothe, B., … Brander, C. (2018).
Benzyl-2-acetamido-2-deoxy-α-d-galactopyranoside increases human immunodeficiency virus replication and viral outgrowth efficacy in vitro.
Frontiers in Immunology, 8(JAN). https://doi.org/10.3389/fimmu.2017.02010
Bravo, I., Álvarez, H., Mariño, A., Clotet, B., & Moltó, J. (2018).
Recurrent coronary disease in HIV-infected patients: role of drug–drug interactions.
British Journal of Clinical Pharmacology, 84(7), 1617–1619. https://doi.org/10.1111/bcp.13583
Salgado, M., Garcia-Minambres, A., Dalmau, J., Jiménez-Moyano, E., Viciana, P., Alejos, B., … Martinez-Picado, J. (2018).
Control of HIV-1 pathogenesis in viremic nonprogressors is independent of Gag-specific cytotoxic T lymphocyte responses.
Journal of Virology, 92(12). https://doi.org/10.1128/JVI.00346-18
Noguera-Julian, M., Guillen, Y., Peterson, J., Reznik, D., Harris, E. V., Joseph, S. J., et al. (2017).
Oral microbiome in HIV-associated periodontitis.
Medicine, 96(12), e5821.
Gomez-Mora, E., Robert-Hebmann, V., Garcia, E., Massanella, M., Clotet, B., Cabrera, C., et al. (2017).
Impaired CD4 T-cell response to autophagy in treated HIV-1-infected individuals.
Jaids-Journal of Acquired Immune Deficiency Syndromes, 74(2), 201-205.
Munoz-Moreno, J. A., Prats, A., Perez-Alvarez, N., Molto, J., Garolera, M., Diez-Quevedo, C., et al. (2016).
Transdermal rivastigmine as adjuvant therapy for HIV-associated neurocognitive disorders.
Journal of Neurovirology, 22, S55-S55.
Munoz-Moreno, J. A., Lopez-Masramon, E., Prats, A., Perez-Alvarez, N., Garolera, M., Ferrer, M. J., et al. (2016).
Accuracy of the NEU screen to detect cognitive impairment in older people with HIV.
Journal of Neurovirology, 22, S55-S56.
Martínez-Bonet, M., González-Serna, A., Clemente, M. I., Morón-López, S., Díaz, L., Navarro, M., et al. (2017).
Relationship between CCR5(WT/d32) heterozygosity and HIV-1 reservoir size in adolescents and young adults with perinatally acquired HIV-1 infection.
Clinical Microbiology and Infection. (Epub 2016 Dec 29)
Biasin, M., Sironi, M., Saulle, I., Pontremoli, C., Garziano, M., Cagliani, R., et al. (2017).
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection.
Microbes and Infection, 19(1), 69-74.
Berenguer, J., Rivero, A., Javier Blasco, A., Ramon Arribas, J., Boix, V., Clotet, B., et al. (2016).
Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS national plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.
Enfermedades Infecciosas y Microbiologia Clinica, 34(6), 361-371.
Lucia, P., Erica, P., Jorge, C., Victor, U., Laura, F. -., Durval, R., et al. (2016).
A cytokine pattern that differentiates pre- from post- seroconversion phases of primary HIV infection.
Journal of Acquired Immune Deficiency Syndromes. (Epub 2016 Dec 23)
Casadellà, M., Cozzi-Lepri, A., Phillips, A., Noguera-Julian, M., Bickel, M., Sedlacek, D., et al. (2017).
Plasma HIV-1 tropism and the risk of short-term clinical progression to AIDS or death.
Plos One, 12(1).
Guillen, Y., Casadellà, M., García-de-la-Guarda, R., Espinoza-Culupú, A., Paredes, R., Ruiz, J., et al. (2016).
Whole-genome sequencing of two bartonella bacilliformis strains.
Genome Announcements, 4(4).
Molinos-Albert, L., Bilbao, Eneritz, Agulló, Luis, Marfil, Silvia, García, Elisabet, Rodríguez de la Concepción, Maria Luisa, Izquierdo-Useros, Nuria, Vilaplana, Cristina, Contreras, F. Xabier, Floor, Martin, Cardona, Pere J., Martinez-Picado, Javier Clotet, Bonaventura Villà-Freixa, Jordi Lorizate, Maier Carrillo, Jorge Blanco Julià.(2017).
Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.
Scientific Reports, 7(40800).
Bonjoch, A., Echeverría, P., Perez-Alvarez, N., Puig, J., Estany, C., Clotet, B., et al. (2016).
Prospective study to assess progression of renal markers after interruption of tenofovir due to nephrotoxicity.
BioMed Research International, 2016.
Samuel, R., Noguera Julian, M., Paredes, R., Parboosing, R., Moodley, P., Singh, L., Gordon, M. (2016).
HIV-1 drug resistance by ultra-deep sequencing following short course zidovudine, single-dose nevirapine, and single-dose tenofovir with emtricitabine for prevention of mother-to-child transmission.
Jaids-Journal of Acquired Immune Deficiency Syndromes, 73(4), 384-389.
Imaz, A., Martinez-Picado, J., Niubo, J., Kashuba, A. D. M., Ferrer, E., Ouchi, D., Podzamczer, D. (2016).
HIV-1-RNA decay and dolutegravir concentrations in semen of patients starting a first antiretroviral regimen.
Journal of Infectious Diseases, 214(10), 1512-1519.
Hamers, R. L., & Paredes, R. (2016).
Next-generation sequencing and HIV drug resistance surveillance.
Lancet Hiv, 3(12), E553-E554.
Rosas, M., Bellido, R., Rocafort, M., Puig, J., Crespo, M., Dorrell, L., et al. (2016).
Mechanisms of abrupt HIV disease progression in a cohort of previous elite and viremic HIV controllers.
AIDS Research and Human Retroviruses, 32, 170-170.
Perez-Santiago, J., Ouchi, D., Urrea, V., Carrillo, J., Cabrera, C., Villa-Freixa, J., et al. (2016).
Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.
Aids, 30(15), 2275-2287.
Molinos-Albert, L. M., Bilbao, E., Agullo, L., Marfil, S., Rodriguez de la Concepcion,Maria Luisa, Garcia, E., et al. (2016).
Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.
AIDS Research and Human Retroviruses, 32, 335-335.
Minuesa, G., Arimany-Nardi, C., Erkizia, I., Cedeño, S., Moltó, J., Clotet, B., et al. (2016).
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
Journal of Antimicrobial Chemotherapy, 71(10), 2782-2792.
Carreras-Sureda, A., Rubio-Moscardo, F., Olvera, A., Argilaguet, J., Kiefer, K., Mothe, B., et al. (2016).
Lymphocyte activation dynamics is shaped by hereditary components at chromosome region 17q12-q21.
Plos One, 11(11).
Williams, B., Mirmonsef, P., Boucher, C. A. B., Bushman, F., Carrington-Lawrence, S., Collman, R. G., et al. (2016).
A summary of the first HIV microbiome workshop 2015.
AIDS Research and Human Retroviruses, 32(10-11), 935-941.
Katlama, C., Lambert-Niclot, S., Assoumou, L., Papagno, L., Lecardonnel, F., Zoorob, R., et al. (2016).
Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: A randomized trial.
Aids, 30(2), 221-230.
Bonjoch, A., Puig, J., Pérez-Alvarez, N., Juega, J., Echeverría, P., Clotet, B., et al. (2016).
Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.
Medicine (United States), 95(32)
Martinez-Picado, J., McLaren, P. J., Erkizia, I., Martin, M. P., Benet, S., Rotger, M., et al. (2016).
Identification of siglec-1 null individuals infected with HIV-1.
Nature Communications, 7
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., et al. (2016).
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.
Jama-Journal of the American Medical Association, 316(2), 171-181.
Videla, S., Sirera, G., Ornelas, A., Pinol, M., Garcia-Cuyas, F., Llatjos, M., et al. (2016).
Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8years of follow-up.
Hiv Medicine, 17(6), 479-481.
Arimany-Nardi, C., Minuesa, G., Keller, T., Erkizia, I., Koepsell, H., Martinez-Picado, J., et al. (2016).
Role of hum an organic cation transporter 1 (hOCT1) polymorphisms in lamivudine (3TC) uptake and drug-drug interactions.
Frontiers in Pharmacology, 7, 175.
Martinez-Picado, J., & Deeks, S. G. (2016).
Persistent HIV-1 replication during antiretroviral therapy.
Current Opinion in Hiv and Aids, 11(4), 417-423.
Noel, N., Peña, R., David, A., Avettand-Fenoel, V., Erkizia, I., Jimenez, E., et al. (2016).
Long-term spontaneous control of HIV-1 is related to low frequency of infected cells and inefficient viral reactivation.
Journal of Virology, 90(13), 6148-6158
Nicolás, D., Esteve, A., Cuadros, A., Campbell, C. N. J., Tural, C., Podzamczer, D., et al. (2016).
Safe reduction in CD4 cell count monitoring in stable, virally suppressed patients with HIV infection or HIV/Hepatitis C virus coinfection.
Clinical Infectious Diseases, 62(12), 1578-1585.
Hosseini, A., Alibés, A., Noguera-Julian, M., Gil, V., Paredes, R., Soliva, R., et al. (2016).
Computational prediction of HIV-1 resistance to protease inhibitors.
Journal of Chemical Information and Modeling, 56(5), 915-923
Pino, M., Erkizia, I., Benet, S., Erikson, E., Fernández-Figueras, M. T., Guerrero, D., et al. (2015).
HIV-1 immune activation induces siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.
Retrovirology, 12, 37.
Santos, J. R., Llibre, J. M., Bravo, I., García-Rosado, D., Cañadas, M. P., Pérez-Álvarez, N., et al. (2016).
Short communication: Efficacy and safety of treatment simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir monotherapy: A randomized clinical trial.
AIDS Research and Human Retroviruses, 32(5), 452-455.
Llibre, J. M., Alvarez, H., Antela, A., Toro, J., Payeras, A., Jesús Pérez-Elías, M., et al. (2016).
Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: A randomized trial.
Journal of Antimicrobial Chemotherapy, 71(5), 1346-1351.
Martin-Iguacel, R., Negredo, E., Peck, R., & Friis-Møller, N. (2016).
Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV.
Current Hypertension Reports, 18(6)
Morón-López, S., Gómez-Mora, E., Salgado, M., Ouchi, D., Puertas, M. C., Urrea, V., et al. (2016).
Short-term treatment with interferon alfa diminishes expression of HIV-1 and reduces CD4+ T-cell activation in patients coinfected with HIV and hepatitis C virus and receiving antiretroviral therapy.
Journal of Infectious Diseases, 213(6), 1008-1012.
Vazquez-Guillen, José Manuel, Palacios-Saucedo, Gerardo C., Rivera-Morales, Lídia G., Garcia-Campos, Jorge, Ortiz-Lopez, Rocío, Noguera-Julian, Marc, et al. (2016).
Mutations related to antiretroviral resistance identified by ultra-deep sequencing in HIV-1 infected children under structured interruptions of HAART.
Plos One, 11(1), e0147591.
Noguera-Julian, M., Cozzi-Lepri, A., Di Giallonardo, F., Schuurman, R., Däumer, M., Aitken, S., et al. (2016).
Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Clinical Microbiology and Infection, 22(2), 191-200.
Moltó, J., Moran, T., Sirera, G., & Clotet, B. (2015).
Lung cancer in HIV-infected patients in the combination antiretroviral treatment era.
Translational Lung Cancer Research, 4(6), 678-688.
Blanco-Heredia, J., Lecanda, A., Valenzuela-Ponce, H., Brander, C., Avila-Rios, S., & Reyes-Teran, G. (2016).
Identification of immunogenic cytotoxic T lymphocyte epitopes containing drug resistance mutations in antiretroviral treatment-naive HIV-infected individuals.
Plos One, 11(1), e0147571.
Rallon, N., Mothe, B., Lopez Bernaldo de Quiros,Juan C., Plana, M., Ligos, J. M., Montoya, M., et al. (2016).
Balance between activation and regulation of HIV-specific CD8(+) T-cell response after modified vaccinia ankara B therapeutic vaccination.
Aids, 30(4), 553-562.
Negredo, E., Bonjoch, A., & Clotet, B. (2016).
Management of bone mineral density in HIV-infected patients.
Expert Opinion on Pharmacotherapy, 17(6), 845-852
Dinges, W., Girard, P. -., Podzamczer, D., Brockmeyer, N. H., García, F., Harrer, T., et al. (2016).
The F4/AS01B HIV-1 vaccine candidate is safe and immunogenic, but does not show viral efficacy in antiretroviral therapy-naive, HIV-1-infected adults: A randomized controlled trial.
Medicine (United States), 95(6).
Coll, J., Molto, J., Boix, J., Gomez-Mora, E., Else, L., Garcia, E., et al. (2015).
Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.
Aids, 29(16), 2149-2154.
Sirera, G., Videla, S., Vergés, J., Chamorro, A., Cañadas, M., & Clotet, B. (2015).
Aggressive human papillomavirus (HPV)-11-related sinonasal inverted papilloma in an HIV-infected patient and the quadrivalent HPV vaccine: A case report.
Aids, 29(17), 2366-2368.
Noguera-Julian, M., Rocafort, M., Guillén, Y., Rivera, J., Casadellà, M., Nowak, P., et al. (2016).
Gut microbiota linked to sexual preference and HIV infection.
Ebiomedicine, 15, 135-146
Jarrin, I., Pantazis, N., Dalmau, J., Phillips, A. N., Olson, A., Mussini, C., et al. (2015).
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?.
Aids, 29(17), 2323-2333.
Casadellà, M., Noguera-Julian, M., Sunpath, H., Gordon, M., Rodriguez, C., Parera, M., et al. (2016).
Treatment options after virological failure of first-line tenofovir-based regimens in south africa: An analysis by deep sequencing.
Aids, 30(7), 1137-40
Ruperez, M., Pou, C., Maculuve, S., Cedeno, S., Luis, L., Rodriguez, J., et al. (2015).
Determinants of virological failure and antiretroviral drug resistance in mozambique.
Journal of Antimicrobial Chemotherapy, 70(9), 2639-2647.
Ternette N., Yang H., Partridge T., Llano A., Cedeño S., Fischer R., . . . Hanke T. (2015).
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cells.
European Journal of Immunology
Santos J.R., Blanco J.L., Masiá M., Gutiérrez F., Pérez-Elías M.J., Iribarren J.A., et al. (2015).
Virological failure to raltegravir in spain: Incidence, prevalence and clinical consequences.
Journal of Antimicrobial Chemotherapy, 70(11), 3087-3095.
Duarte, R. F., Salgado, M., Sanchez-Ortega, I., Arnan, M., Canals, C., Domingo-Domenech, E., et al. (2015).
CCR5 delta 32 homozygous cord blood allogeneic transplantation in a patient with HIV: A case report.
Lancet Hiv, 2(6), E236-E242
Shahid, A., Olvera, A., Anmole, G., Kuang, X. T., Cotton, L. A., Plana, M., et al. (2015).
Consequences of HLA-B*13-associated escape mutations on HIV-1 replication and nef function.
Journal of Virology, 89(22), 11557-11571.
Casadellá, M., van Ham, P. M., Noguera-Julian, M., van Kessel, A., Pou, C., Hofstra, L. M., et al. (2015).
Primary resistance to integrase strand-transfer inhibitors in europe.
Journal of Antimicrobial Chemotherapy,70(10), 2885-2888.
Sironi, M., Biasin, M., Pontremoli, C., Cagliani, R., Saulle, I., Trabattoni, D., et al. (2015).
Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection.
Retrovirology, 12, 80.
Martínez-Bonet, M., Puertas, M. C., Fortuny, C., Ouchi, D., Mellado, M. J., Rojo, P., et al. (2015).
Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy.
Clinical Infectious Diseases, 61(7), 1169-1178.
Guardo, A. C., Ruiz-Riol, M., Fernández, E., Maleno, M. J., Bargalló, M. E., León, A., et al. (2015).
Detection of HIV-1-specific T-cell immune responses in highly HIV-exposed uninfected individuals by in-vitro dendritic cell co-culture.
Aids, 29(11), 1309-1318.
Santos, J. R., Saumoy, M., Curran, A., Bravo, I., Llibre, J. M., Navarro, J., et al. (2015).
The lipid-lowering effect of Tenofovir/Emtricitabine: A randomized, crossover, double-blind, placebo-controlled trial.
Clinical Infectious Diseases, 61(3), 403-408
Negredo, E., Bonjoch, A., Perez-Alvarez, N., Ornelas, A., Puig, J., Herrero, C., et al. (2015).
Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: Single dose versus two doses in 2 years.
Hiv Medicine, 16(7), 441-448.
Guardiola, M., Echeverria, P., Gonzalez, M., Vallve, J. C., Puig, J., Clotet, B., et al. (2015).
Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.
AIDS Research and Human Retroviruses, 31(9), 882-888.
Perez-Alvarez, S., Gómez, G., & Brander, C. (2015).
FARMS: A new algorithm for variable selection.
BioMed Research International, 2015.
Negredo, E., Puig, J., Ornelas, A., Echeverría, P., Bonjoch, A., Estany, C., et al. (2015).
Ten-year safety with polyacrylamide gel used to correct facial lipoatrophy in HIV-infected patients.
AIDS Research and Human Retroviruses, 31(8), 817-821.
Andreu-Crespo, À., Llibre, J. M., Cardona-Peitx, G., Sala-Piñol, F., Clotet, B., & Bonafont-Pujol, X. (2015).
Hidden costs of antiretroviral treatment: The public health efficiency of drug packaging.
Drug Design, Development and Therapy, 9, 4287-4290.
Negredo, E., Diez-Pérez, A., Bonjoch, A., Domingo, P., Pérez-Álvarez, N., Gutierrez, M., et al. (2014).
Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: Changes in bone turnover markers and circulating sclerostin levels.
Journal of Antimicrobial Chemotherapy, 70(7), 2104-2107.
Massanella, M., Gómez-Mora, E., Carrillo, J., Curriu, M., Ouchi, D., Puig, J., et al. (2015).
Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.
Journal of Translational Medicine, 13(1).
Duarte, RF; Salgado, M.; …Clotet, B. ; Martínez-Picado, et al. (2015).
CCR5 32 homozygous cord blood allogeneic transplantation in a patient with HIV: A case report.
The Lancet HIV, vol. 2, n. 6, pp. 236-242
Tiraboschi, J. M., Muñoz-Moreno, J. A., Puertas, M. C., Alonso-Villaverde, C., Prats, A., Ferrer, E., Martínez-Picado, J., et al. (2015).
Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
HIV Medicine, 16(6), 388-392.
Di Yacovo, M. S., Moltó, J., Ferrer, E., Curran, A., Else, L., Gisslén, M., et al. (2014).
Antiviral activity and CSF concentrations of 600/100 mg of darunavir/ritonavir once daily in HIV-1 patients with plasma viral suppression.
Journal of Antimicrobial Chemotherapy, 70(5), 1513-1516
Pino, M., Erkizia, I., Benet, S., Erikson, E., Fernández-Figueras, M. T., Guerrero, D., et al. (2015).
HIV-1 immune activation induces siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.
Retrovirology, 12(1).
Velasco, C., Parker, E., Pastor, L., Nhama, A., Macuacua, S., Mandomando, I., et al. (2015).
Rapid HIV progression during acute HIV-1 subtype C infection in a mozambican patient with atypical seroconversion.
American Journal of Tropical Medicine and Hygiene, 92(4), 681-683.
Surdo, M., Alteri, C., Puertas, M. C., Saccomandi, P., Parrotta, L., Swenson, L., et al. (2015).
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029.
Clinical Microbiology and Infection, 21(1), 103.e1-103.e6.
Santos, J. R., Llibre, J. M., Berrio-Galan, D., Bravo, I., Miranda, C., Pérez-Alvarez, S., et al. (2014).
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
Journal of Antimicrobial Chemotherapy, 70(4), 1124-1129.
Moltó, J., Valle, M., Ferrer, E., Domingo, P., Curran, A., Santos, J. R., et al. (2014).
Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: A randomized clinical trial.
Journal of Antimicrobial Chemotherapy, 70(4), 1139-1145.
Llibre, J. M., & Clotet, B. (2015).
Resistance profile and genetic barrier of dolutegravir. [Perfil de resistencias y barrera genética de dolutegravir].
Enfermedades Infecciosas y Microbiologia Clinica, 33(S1), 20-25.
Cozzi-Lepri, A., Noguera-Julian, M., Di Giallonardo, F., Schuurman, R., Daeumer, M., Aitken, S., et al. (2015).
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: A multicohort european case-control study using centralized ultrasensitive 454 pyrosequencing.
Journal of Antimicrobial Chemotherapy, 70(3), 930-940.
Olvera, A., Perez-Alvarez, S., Lbarrondo, J., Ganoza, C., Lama, J. R., Lucchetti, A., et al. (2015).
The HLA-C*04:01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.
Aids, 29(5), 507-517.
Carrillo, J., Molinos-Albert, L. M., De La Concepción, M. L. R., Marfil, S., Garciá, E., Derking, R., et al. (2015).
Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individuals.
Plos One, 10(3).
Mothe, B., Hu, X., Llano, A., Rosati, M., Olvera, A., Kulkarni, V., et al. (2015).
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques.
Journal of Translational Medicine, 13:60.
Berger, C. T., Llano, A., Carlson, J. M., Brumme, Z. L., Brockman, M. A., Cedeño, S., et al. (2015).
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.
Journal of Virology, 89(7), 4015-4019.
Ruiz-Riol, M., Llano, A., Ibarrondo, J., Zamarreño, J., Yusim, K., Bach, V., et al. (2015).
Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected
Journal of Infectious Diseases, 211(6), 936-946.
Echeverria, P., Guardiola, M., González, M., Vallvé, J. C., Bonjoch, A., Puig, J., et al. (2015).
Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients
Antiviral Research, 114, 48-52.
Massanella, M., Ouchi, D., Marfil, S., Llibre, J. M., Puertas, M. C., Buzon, M. J., Clotet, B. et al. (2014).
Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals
Plos One, 9(12), e114142.
Ramon Santos, J., Saumoy, M., Curran, A., Bravo, I., Navarro, J., Estany, C., Clotet, B. et al. (2014).
Randomized, crossover, double-blind, placebo-controlled trial to assess the lipid lowering effect of co-formulated TDF/FTC
Journal of the International Aids Society, 17, 42-42.
Yaciuk JC, Skaley M, Bardet W, Schafer F, Mojsilovic D, Cate S, Stewart CJ, McMurtrey C, Jackson KW, Buchli R, Olvera A, Cedeño S, Plana M, Mothe B, Brander C, West JT, Hildebrand WH (2014).
Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells
Journal of Virology, 88(22),12992-13004.
Darwich, L., Cañadas, M. P., Videla, S., Coll, J., Molina-López, R. A., Cobarsi, P., et al. (2014).
Oral human papillomavirus type-specific infection in HIV-infected men: A prospective cohort study among men who have sex with men and heterosexual men.
Clinical Microbiology and Infection, 20, september (9), 0585-0589
Olvera, A., Ganoza, C., Perez-Alvarez, S., Hildebrand, W., Sanchez, J., & Brander, C. (2014).
HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a peruvian MSM cohort
Aids, 28(15), 2323-2325.
Bonjoch, A., Juega, J., Puig, J., Pérez-Alvarez, N., Aiestarán, A., Echeverría, P., et al. (2014).
High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: Evaluation of associated factors
AIDS Patient Care and STDs, 28(10), 1-6.
Muñoz-Moreno, J. A., Pérez-Álvarez, N., Muñoz-Murillo, A., Prats, A., Garolera, M., Jurado, M. A., et al. (2014).
Classification models for neurocognitive impairment in HIV infection based on demographic and clinical variables
Plos One, 9, september(9),
Puertas, M. C., Salgado, M., López, S. M., Ouchi, D., Muñoz-Moreno, J. A., Moltó, J., et al. (2014).
Effect of lithium on HIV-1 expression and proviral reservoir size in the CD4+ T cells of antiretroviral therapy suppressed patients.
Aids, 28(14), 2157-2159. 10.1097/QAD.0000000000000373
Podzamczer, D., Imaz, A., Perez, I., Viciana, P., Valencia, E., Curto, J., et al. (2014).
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: A multicentre experience in antiretroviral therapy-naive and -experienced patients.
Journal of Antimicrobial Chemotherapy, 69(9), pp. 2536-2540. 10.1093/jac/dku157
Franco, S., Tural, C., Nevot, M., Moltó, J., Rockstroh, J. K., Clotet, B., et al. (2014).
Detection of a sexually transmitted hepatitis C virus protease inhibitor-resistance variant in a human immunodeficiency virus-infected homosexual man.
Gastroenterology, 147(3), 599-601.e1.
Arimany-Nardi, C., Errasti-Murugarren, E., Minuesa, G., Martínez-Picado, J., Gorboulev, V., Koepsell, H., et al. (2014).
Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.
British Journal of Pharmacology, 171(16), 3868-3880.10.1111/bph.12748
Pou, C., Noguera-Julian, M., Pérez-Álvarez, S., García, F., Delgado, R., Dalmau, D., et al. (2014).
Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.
Clinical Infectious Diseases, 59(4), 578-588.10.1093/cid/ciu287
Izquierdo-Useros, N., Lorizate, M., McLaren, P. J., Telenti, A., Kräusslich, H. -., & Martínez-Picado, J. (2014).
HIV-1 capture and transmission by dendritic cells: The role of viral glycolipids and the cellular receptor siglec-1.
PLoS Pathogens, 10(7). 10.1371/journal.ppat.1004146
Echeverria, P., Domingo, P., Llibre, J., Gutierrez, M., Mateo, G., Puig, J., et al. (2014).
Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: Results from a mediterranean cohort of HIV-infected patients.
Biomed Research International, , 823058. http://dx.doi.org/10.1155/2014/823058